- Allergy
- Aspergillosis
- B19 parvovirus
- Bacterial infections
- Blastomycosis
- Cancers - overview
- Candidiasis
- Cardiomyopathy
- Coccidioidomycosis
- Cryptococcus
- Cryptosporidiosis
- Cytomegalovirus (CMV) - overview
- Cytomegalovirus (CMV) - key research on treatment
- Cytomegalovirus (CMV) - key research on prophylaxis
- Cytomegalovirus (CMV) - references
- Depression
- Diabetes
- Entamoeba histolytica
- Giardia lamblia
- Gingivitis
- Guillain-Barré syndrome
- Gynaecomastia (breast enlargement)
- Hairy leukoplakia
- Hepatitis A
- Hepatitis B
- Hepatitis C - overview
- Hepatitis C - key research
- Hepatitis C - references
- Herpes simplex
- Histoplasmosis
- HIV-associated dementia - overview
- HIV-associated dementia - key research
- HIV-associated dementia - references
- HIV-associated salivary disease
- Hodgkin's disease
- Human herpes virus 6
- Human papilloma virus
- Isosporiasis
- Kaposi's sarcoma - overview
- Kaposi's sarcoma - key research
- Kaposi's sarcoma - references
- Lactic acidosis / acidaemia
- Leishmaniasis
- Lung cancer
- Lymphocytic interstitial pneumonitis
- Malaria
- Microsporidiosis
- Molluscum contagiosum
- Multicentric Castleman's disease
- Mycobacterium avium intracellulare (MAI) - overview
- Mycobacterium avium intracellulare (MAI) - key research
- Mycobacterium avium intracellulare (MAI) - references
- Mycobacterium haemophilum
- Mycobacterium kansasii
- Neuropathy
- Neutropenia
- Non-Hodgkin's lymphoma
- Osteonecrosis
- Osteoporosis
- Pancreatitis
- Pelvic inflammatory disease
- Penicilliosis
- Persistent generalised lymphadenopathy
- Pneumocystis pneumonia (PCP) - overview
- Pneumocystis pneumonia (PCP) - prevention & prophylaxis key research
- Pneumocystis pneumonia (PCP) - treatment key research
- Pneumocystis pneumonia (PCP) - references
- Progressive multifocal leukoencephalopathy (PML)
- Psoriasis
- Pulmonary arterial hypertension
- Q fever
- Renal (kidney) disease
- Salmonellosis
- Schistosomiasis and other worm and fluke infections
- Seborrhoeic dermatitis
- Syphilis
- Testicular cancer
- Testosterone deficiency
- Thrombocytopenia
- Thrombotic thrombocytopenic purpura
- Tinea
- Toxoplasmosis - overview
- Toxoplasmosis - treatment key research
- Toxoplasmosis - prophylaxis key research
- Toxoplasmosis - references
- Tuberculosis
- Ulcers
- Vacuolar myelopathy
- Varicella zoster virus
- Wasting syndrome - overview
- Wasting syndrome - key research
- Wasting syndrome - references
Cardiomyopathy
Cardiomyopathy means heart disease of unknown cause. One form of cardiomyopathy called dilated cardiomyopathy, is characterised by poor contraction of the heart muscles. Recent reports have found that people with HIV have a high rate of dilated cardiomyopathy and that HIV may be a cause of that condition.
Dilated cardiomyopathy is suggestive of a poorer prognosis among people with HIV disease. HIV-infected people also have higher than average rates of left ventricular hypertrophy - a condition where the heart swells to compensate for its increasing weakness.
Regular heart and lung check-ups may allow early diagnosis and treatment of heart conditions.
Mechanism and risk factors
The role HIV plays in the development of heart disease is not understood. It may directly impact on heart cells, or induce disease through the dysregulation of the immune system or coinfection with other viruses. Poor nutrition and wasting may also contribute to heart disease, and anecdotal reports have suggested that antiretroviral therapy including protease inhibitors may increase a person's risk of heart disease.
Key research
Barbaro undertook a long-term, prospective study to assess the incidence of dilated cardiomyopathy among people with HIV and to analyse clinical factors influencing its development. 952 HIV-positive people were followed for an average of 60 months. 76 (8%) were diagnosed with dilated cardiomyopathy, of whom 63 also had myocarditis (inflammation of the muscle in the heart wall). Researchers did not determine the causal mechanism but suggested two possibilities: the direct action of HIV on the heart, or an autoimmune process induced by HIV, possibly in conjunction with other viruses such as EBV or CMV.
References
Barbaro G et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo studio cardiologico dei pazienti affetti da AIDS. New England Journal of Medicine 339(16): 1093-1099, 1998. Lipshultz SE. Dilated cardiomyopathy in HIV-infected patients. New England Journal of Medicine 339(16): 1153-1155, 1998.
latest aidsmap news
- Large HIV vaccine study will not go ahead
- Swiss court rules all people with HIV can be criminally liable for transmission, even if untested
- Genital shedding of HIV in women with undetectable viral load: less of it, but still happening
- Microbicides could prevent more infections in men than in women
- Knowledge of STIs poor in rural Tanzania - associated with risky sex and infection with HIV
- HIV treatment effective for infants in resource-limited settings
- Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
- One third of people with HIV have experienced sexual difficulties in the past month
- Differing causes of lung infections in HIV-positive patients: implications for diagnosis and treatment
- Roche to halt HIV drug research
